AgingResearch.NewsJoin free

MIR-871-5P inhibitor

Intervention

1 paper studies it1 finding

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funder: National Natural Science Foundation of China
  • Cells1

Outcomes

1

Hepatic steatosis

downin cells1

1 study

  1. MIR-871-5P inhibitor decreases hepatic steatosis in cells.

    “Conversely, miR-871-5p inhibitor promoted PGC1α expression and reduced lipid deposition in senescent hepatocytes.”

    Cellsin AML12 senescent hepatocytesliver

    miR-871-5p/PGC1α Regulates Aging-Induced Lipid Deposition in Hepatocytes Through Fatty Acid β-Oxidation

    The journals of gerontology. Series A, Biological sciences and medical sciencesAug 4, 2023

More on Hepatic steatosis

Latest

Related